Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
PGIM Jennison Rising Dividend Z PJDZX
- NAV / 1-Day Return 18.22 / +0.50 %
- Total Assets 101.2 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.000%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Large Blend
- Investment Style Large Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 1.13%
- Turnover 106%
USD | NAV as of Mar 18, 2024 | 1-Day Return as of Mar 18, 2024, 10:23 PM GMT+0
Morningstar’s Analysis PJDZX
Will PJDZX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 33.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 4.56 | 5.5 Mil | Healthcare |
Lam Research Corp | 3.78 | 4.5 Mil | Technology |
AbbVie Inc | 3.47 | 4.2 Mil | Healthcare |
Parker Hannifin Corp | 3.29 | 3.9 Mil | Industrials |
Apple Inc | 3.24 | 3.9 Mil | Technology |
Eaton Corp PLC | 3.15 | 3.8 Mil | Industrials |
Constellation Energy Corp | 2.98 | 3.6 Mil | Utilities |
ASML Holding NV ADR | 2.97 | 3.6 Mil | Technology |
AstraZeneca PLC ADR | 2.89 | 3.5 Mil | Healthcare |
JPMorgan Chase & Co | 2.87 | 3.5 Mil | Financial Services |